MAZZONE, MASSIMILIANO
 Distribuzione geografica
Continente #
AS - Asia 2.925
NA - Nord America 2.564
SA - Sud America 521
EU - Europa 389
Continente sconosciuto - Info sul continente non disponibili 157
AF - Africa 53
OC - Oceania 3
Totale 6.612
Nazione #
US - Stati Uniti d'America 2.454
SG - Singapore 1.784
CN - Cina 499
BR - Brasile 438
VN - Vietnam 269
IT - Italia 148
HK - Hong Kong 125
CA - Canada 55
GB - Regno Unito 44
BD - Bangladesh 41
IN - India 36
DE - Germania 34
ES - Italia 31
MX - Messico 29
AR - Argentina 23
IQ - Iraq 23
FR - Francia 22
JP - Giappone 22
EC - Ecuador 20
TR - Turchia 19
ZA - Sudafrica 18
PL - Polonia 17
RU - Federazione Russa 16
PK - Pakistan 15
ID - Indonesia 14
UA - Ucraina 13
UZ - Uzbekistan 13
NL - Olanda 12
PY - Paraguay 11
AT - Austria 10
KE - Kenya 8
CO - Colombia 7
IE - Irlanda 7
SE - Svezia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CZ - Repubblica Ceca 6
EG - Egitto 6
PH - Filippine 6
JO - Giordania 5
MY - Malesia 5
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
HN - Honduras 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
PS - Palestinian Territory 4
UY - Uruguay 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
FI - Finlandia 3
IL - Israele 3
MN - Mongolia 3
NP - Nepal 3
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
IR - Iran 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
OM - Oman 2
PT - Portogallo 2
TW - Taiwan 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MZ - Mozambico 1
NI - Nicaragua 1
NR - Nauru 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 6.454
Città #
Singapore 735
San Jose 479
Ashburn 418
The Dalles 313
Beijing 174
Shanghai 173
Dallas 169
Council Bluffs 156
Hong Kong 119
Ho Chi Minh City 99
Santa Clara 84
Hanoi 63
Los Angeles 56
Milan 53
New York 51
São Paulo 37
Seattle 32
Boardman 30
Montreal 23
Assago 20
Chandler 18
Buffalo 17
Da Nang 17
Rome 17
Warsaw 17
Rio de Janeiro 16
Chicago 15
Orem 15
Tokyo 15
Wilmington 14
Denver 13
Mexico City 13
Tashkent 12
Belo Horizonte 11
Brooklyn 11
Amsterdam 10
Atlanta 10
Curitiba 10
Houston 10
Hải Dương 10
Johannesburg 10
Murcia 10
Boston 9
Haiphong 9
London 9
Brasília 8
Chennai 8
Manchester 8
Porto Alegre 8
Abbiategrasso 7
Ankara 7
Dhaka 7
Dublin 7
Figino 7
Munich 7
San Mateo 7
São José dos Campos 7
Baghdad 6
Basra 6
Charlotte 6
Guayaquil 6
Istanbul 6
Nairobi 6
Naples 6
Paris 6
Phoenix 6
Stockholm 6
Vienna 6
Amman 5
Arapiraca 5
Biên Hòa 5
Cape Town 5
Columbus 5
Joinville 5
Lahore 5
Lima 5
Miami 5
Mumbai 5
Philadelphia 5
Quito 5
Reston 5
San Francisco 5
Turin 5
Asunción 4
Belém 4
Bến Tre 4
Cairo 4
Cuenca 4
Erbil 4
Florence 4
Fortaleza 4
Goiânia 4
Islamabad 4
Jacobina 4
Kuala Lumpur 4
Louisville 4
Madrid 4
Milwaukee 4
Montevideo 4
Newark 4
Totale 3.899
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 156
Monocyte biomarkers for cancer detection 112
PHD2 inhibition for blood vessel normalization, and uses thereof 98
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 84
"Active" cancer immunotherapy by anti-Met antibody gene transfer 82
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 78
Modulating transendothelial migration and recruitment of granulocytes by modulating c-Met pathway 68
Tumor-associated macrophages: a short compendium 67
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels 59
Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia 59
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates 58
The PP2A B55a subunit as novel PHD2 interacting protein and implications for cancer 58
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer 56
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming 56
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis 56
The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells 55
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells 55
YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis 54
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization 54
Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation 54
Building in resistance to endothelial cell death 54
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2 54
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling 53
B55α/PP2A limits endothelial cell apoptosis during vascular remodeling: A complementary approach to disrupt pathological vessels? 52
BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis 52
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis 51
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer 51
Induction/monitoring of arteriogenesis using SDF1 and PDGFB or inhibition of PHD2 51
Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way 51
Blood Vessel Proximity Shapes Cancer Cell Metabolism 51
SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism 51
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 51
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 51
Overcoming Resistance to Antiangiogenic Therapies 50
Genetic targeting of the kinase activity of the Met receptor in cancer cells 50
Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness 50
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis 49
The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo 49
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth 49
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization 49
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity 49
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 49
Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis 49
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma 48
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia 48
The Met pathway: master switch and drug target in cancer progression 48
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited 48
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene 48
Neutrophils enhance early Trypanosoma brucei infection onset 48
Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation 48
Metabolic traits ruling the specificity of the immune response in different cancer types 48
FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? 47
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 47
Brain Endothelial Cells Control Fertility through Ovarian-Steroid-Dependent Release of Semaphorin 3A 47
Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting 46
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties 46
Caspase-8 modulates physiological and pathological angiogenesis during retina development 46
A collaborative synthetase 46
Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival 46
Macrophage-derived glutamine boosts satellite cells and muscle regeneration 46
Leptin brain entry via a tanycytic LepR–EGFR shuttle controls lipid metabolism and pancreas function 45
IL1b promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D 45
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? 45
Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population 45
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 45
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity 44
Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis 44
PHD1 regulates p53-mediated colorectal cancer chemoresistance 44
Tumour hypoxia causes DNA hypermethylation by reducing TET activity 43
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis 43
Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury 43
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer 42
Growing tumor vessels: More than one way to skin a cat - Implications for angiogenesis targeted cancer therapies 42
Hypoxia determines survival outcomes of bacterial infection through HIF-1α–dependent reprogramming of leukocyte metabolism 42
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform 41
Immunity, hypoxia, and metabolism–the ménage à trois of cancer: Implications for immunotherapy 41
Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization 40
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 40
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis 40
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium 40
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 40
Metabolism and TAM functions—it takes two to tango 40
MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability 39
Role of delta-like-4/notch in the formation and wiring of the lymphatic network in zebrafish 39
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 39
The impact of hypoxia on tumor-associated macrophages 39
Role and therapeutic potential of VEGF in the nervous system 39
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism 39
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF 39
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice 39
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models 39
Drug discovery: A lifeline for suffocating tissues 39
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 38
MiR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 38
Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis 38
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation 38
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner 38
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? 38
Tumor vessel co-option probed by single-cell analysis 38
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy 38
Totale 5.014
Categoria #
all - tutte 39.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 0 0 0 3 0 0 0 2 0 2 6 5
2022/202345 5 2 3 7 2 4 0 5 11 3 3 0
2023/2024529 0 3 3 3 2 4 2 1 146 27 145 193
2024/20251.454 45 5 4 14 11 118 83 92 301 392 184 205
2025/20264.210 638 357 245 295 141 242 1.233 187 217 277 145 233
2026/2027330 125 205 0 0 0 0 0 0 0 0 0 0
Totale 6.612